Evidence map›Paper›PMID 29724491›Full record

ArticleBiological psychiatry2019

Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP.

Anke Van Dijck, Anneke T Vulto-van Silfhout, Elisa Cappuyns, Ilse M van der Werf, Grazia M Mancini, Andreas Tzschach, Raphael Bernier, Illana Gozes, Evan E Eichler, Corrado Romano and 11 more

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 99 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
99citing papers in PubMed, 1 pooled it
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

99 citing papers in PubMed, 1 synthesis or guideline pooled it, 178 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Diagnostics (Basel, Switzerland) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Comprehensive analysis ofmedRxiv : the preprint server for health sciences · 2026
    Article
  8. Article
  9. Transient visual evoked potential abnormalities in ADNP syndrome.Journal of neurodevelopmental disorders · 2026
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Synaptic Deficits in Adnp-Mutant Mice Are Ameliorated by Histone Demethylase LSD1 Inhibition.Autism research : official journal of the International Society for Autism Research · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. The chromatin remodeler ADNP regulates neurodevelopmental disorder risk genes and neocortical neurogenesis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article

39 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 11 institutions in 8 countries.

Anke Van DijckDepartment of Medical Genetics, University of Antwerp, Antwerp, Belgium; Department of Neurology, University Hospital Antwerp, Antwerp, Belgium. Electronic address: anke.vandijck@uantwerpen.be.
Anneke T Vulto-van SilfhoutDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
Elisa CappuynsDepartment of Medical Genetics, University of Antwerp, Antwerp, Belgium.
Ilse M van der WerfDepartment of Medical Genetics, University of Antwerp, Antwerp, Belgium.
Grazia M ManciniDepartment of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands.
Andreas TzschachInstitute für Klinische Genetik, Technische Universität Dresden, Dresden, Germany.
Raphael BernierDepartment of Psychiatry, University of Washington, Seattle, Washington.
Illana GozesElton Laboratory for Molecular Neuroendocrinology, Tel Aviv University, Tel Aviv, Israel; Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel; Adams Super Center for Brain Studies, Tel Aviv University, Tel Aviv, Israel.
Evan E EichlerDepartment of Genome Sciences, University of Washington, Seattle, Washington; Howard Hughes Medical Institute, University of Washington, Seattle, Washington.
Corrado RomanoUnit of Pediatrics and Medical Genetics, Istituto di Ricovero e Cura a Carattere Scientifico Associazione Oasi Maria Santissima, Troina, Italy.
Anna LindstrandDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Ann NordgrenDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
ADNP Consortium
Malin KvarnungDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Tjitske KleefstraDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
Bert B A de VriesDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.
Sébastien KüryService de Génétique Médicale, Centre Hospitalier Universitaire Nantes, Nantes, France.
Jill A RosenfeldDepartment of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas.
Marije E MeuwissenDepartment of Medical Genetics, University of Antwerp, Antwerp, Belgium.
Geert VandeweyerDepartment of Medical Genetics, University of Antwerp, Antwerp, Belgium.
R Frank KooyDepartment of Medical Genetics, University of Antwerp, Antwerp, Belgium.
University of Antwerp · BEKarolinska Institutet · SERadboud University Nijmegen · NLBaylor College of Medicine · USCentre Hospitalier Universitaire de Nantes · FRErasmus MC · NLHoward Hughes Medical Institute · USOasi Maria SS · ITTechnische Universität Dresden · DETel Aviv University · ILUniversity of Washington · US

Funding

Sporadic Mutations and Autism Spectrum DisordersR01MH101221 · NIMH · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2013 to 2025
$9.2M
Intellectual and Developmental Disabilities Research CenterU54HD083091 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 2014 to 2019
$7.9M
Chief Scientist OfficeHoward Hughes Medical InstituteNICHD NIH HHS U54 HD083091NIMH NIH HHS R01 MH101221Wellcome TrustWellcome Trust WT098051
6 · The paper itself

Abstract

backgroundIn genome-wide screening studies for de novo mutations underlying autism and intellectual disability, mutations in the ADNP gene are consistently reported among the most frequent. ADNP mutations have been identified in children with autism spectrum disorder comorbid with intellectual disability, distinctive facial features, and deficits in multiple organ systems. However, a comprehensive clinical description of the Helsmoortel-Van der Aa syndrome is lacking.

methodsWe identified a worldwide cohort of 78 individuals with likely disruptive mutations in ADNP from January 2014 to October 2016 through systematic literature search, by contacting collaborators, and through direct interaction with parents. Clinicians filled in a structured questionnaire on genetic and clinical findings to enable correlations between genotype and phenotype. Clinical photographs and specialist reports were gathered. Parents were interviewed to complement the written questionnaires.

resultsWe report on the detailed clinical characterization of a large cohort of individuals with an ADNP mutation and demonstrate a distinctive combination of clinical features, including mild to severe intellectual disability, autism, severe speech and motor delay, and common facial characteristics. Brain abnormalities, behavioral problems, sleep disturbance, epilepsy, hypotonia, visual problems, congenital heart defects, gastrointestinal problems, short stature, and hormonal deficiencies are common comorbidities. Strikingly, individuals with the recurrent p.Tyr719* mutation were more severely affected.

conclusionsThis overview defines the full clinical spectrum of individuals with ADNP mutations, a specific autism subtype. We show that individuals with mutations in ADNP have many overlapping clinical features that are distinctive from those of other autism and/or intellectual disability syndromes. In addition, our data show preliminary evidence of a correlation between genotype and phenotype.

Indexed as

Abnormalities, MultipleAdolescentAdultAutism Spectrum DisorderChildChild, PreschoolCohort StudiesFemaleHomeodomain ProteinsHumansInfantIntellectual DisabilityMaleMutationNerve Tissue ProteinsNeurodevelopmental DisordersADNP protein, humanHomeodomain ProteinsNerve Tissue ProteinsADNPAutismGeneticsHelsmoortel-Van der Aa syndromeIntellectual disabilityNeurodevelopmental disorder

Identifiers

PMID29724491
PMCPMC6139063
OpenAlexW2793838986

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.